|
Neuropsychiatric events linked to asthma medication
AAP News (subscription) Montelukast is approved to treat asthma and symptoms of allergic rhinitis and to prevent exercise-induced asthma. Warnings regarding increased risk of neuropsychiatric events were added to the product label for montelukast and other leukotriene … |
View full post on asthma – Google News